202,725 Shares in Astera Labs, Inc. $ALAB Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 202,725 shares of the company’s stock, valued at approximately $97,920,000.

A number of other large investors also recently added to or reduced their stakes in the business. Reflection Asset Management acquired a new stake in shares of Astera Labs during the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC raised its stake in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs in the fourth quarter valued at approximately $33,000. Whipplewood Advisors LLC lifted its holdings in Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the period. Finally, Assetmark Inc. boosted its stake in Astera Labs by 78.9% in the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after acquiring an additional 101 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Performance

Shares of ALAB opened at $303.44 on Wednesday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The firm’s 50 day moving average price is $356.72 and its two-hundred day moving average price is $242.75. The firm has a market cap of $52.64 billion, a P/E ratio of 150.22 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the firm earned $0.44 earnings per share. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on ALAB shares. TD Cowen lowered their target price on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

Insider Activity at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $1,092,964.15. Following the completion of the transaction, the director directly owned 53,961 shares of the company’s stock, valued at approximately $16,826,658.63. This represents a 6.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 631,979 shares of company stock valued at $215,479,247. 10.40% of the stock is owned by insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.